Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print January 2, 2008
DOI: 10.2337/db07-1358

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1358v1
db07-1358v2
57/4/1115    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polak, M.
Right arrow Articles by Vaxillaire DPharm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polak, M.
Right arrow Articles by Vaxillaire DPharm, M.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Heterozygous Missense Mutations in the Insulin Gene are linked to Permanent Diabetes appearing in the Neonatal Period or in Early-Infancy: A report from the French ND Study Group

Michel Polak, MD, PhD1,2,3, Aurélie Dechaume, MSc4,5, Hélène Cavé DPharm, PhD6, Revital Nimri, MD7, Hélène Crosnier, MD8, Véronique Sulmont, MD9, Marc de Kerdanet, MD10, Raphael Scharfmann, PhD1,2, Yael Lebenthal, MD7, Philippe Froguel, MD, PhD4,5,11, and Martine Vaxillaire DPharm, PhD4,5

1Faculty of Medicine, René Descartes Paris 5 University, Paris, France
2Inserm, U845, Necker Enfants Malades Hospital, Paris, France
3Department of Pediatric Endocrinology, Necker Enfants Malades Hospital, Paris, France
4CNRS, 8090, Institute of Biology, Pasteur Institute, Lille, France
5University of Lille 2, Lille, France
6Genetic Biochemistry, Robert Debré Hospital, Paris, France
7Pediatric Endocrinology and Diabetes, Schneider Medical Center, Petah Tikva, Israel
8 Department of Pediatrics, Saint-Germain en Laye Hospital, Saint-Germain en Laye, France
9Pediatric Endocrinology, Franco-American Hospital, Reims, France
10Pediatric Endocrinology, Hôpital Sud, Rennes, France
11Genomic Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom

Objective: Permanent neonatal diabetes (PND) is defined by chronic hyperglycemia due to severe non-autoimmune insulin deficiency diagnosed in the first months of life. Several genes, including KCNJ11 and ABCC8 which encode the two subunits of the ATP-sensitive K+ (KATP) channel, can cause PND. Mutations in the Insulin (INS) gene have been recently described in ND families. Our study aimed to investigate the genetic anomalies and clinical heterogeneity in PND patients who are negative for a KATP channel mutation.

Research Design and Methods: We screened the INS gene by direct sequencing in 38 PND patients and in one child with non-autoimmune early-infancy diabetes, where no mutation in GCK, KCNJ11 and ABCC8 was identified. A detailed clinical phenotyping of the patients was carried out to specify the diabetes features in those found with an INS mutation.

Results: We identified 3 missense mutations in the INS gene in 4 probands. 2/4 mutations were inherited in a dominant manner, and the familial description evidenced a marked variability in age of diagnosis and disease progression. In our cohort, the INS mutations may represent ~10% of all permanent ND cases, having a later presentation of diabetes and no associated symptoms compared to cases with KATP channel mutations.

Conclusions: Heterozygous INS gene mutations can cause isolated permanent early-infancy diabetes, and should be assessed in neonatal as well as in childhood diabetes appearing like type 1, when autoimmune markers are absent. New pharmacogenomic strategies may be applicable as residual β-cell function is still present in some patients.


Key Words: Diabetes • Genetics • Insulin biosynthesis • Insulin gene • Mutation • Neonatal diabetes


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

Insulin Mutations in Diabetes: The Clinical Spectrum
Benjamin Glaser
Diabetes 2008 57: 799-800. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
DiabetesHome page
B. Glaser
Insulin Mutations in Diabetes: The Clinical Spectrum
Diabetes, April 1, 2008; 57(4): 799 - 800.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.